| Abstract | The anti-PA IgG1, IgG2, IgG3, and IgG4 subclass responses to clinical anthrax and to different numbers of anthrax vaccine adsorbed (AVA, BioThrax) injections were determined in a cross-sectional study of sera from 63 vaccinees and 13 clinical anthrax patients. The data show that both vaccination with three AVA injections and clinical anthrax elicit anti-PA IgG1, IgG2, and IgG3 subclass responses. An anti-PA IgG4 response was detected in AVA recipients after the fourth injection. The anthrax lethal toxin (LTx) neutralization efficacy of sera from recipients who received 4 to > or =10 AVA injections did not vary significantly in relation to changes in distribution of anti-PA IgG1 and IgG4 subclasses. |
| Authors | V A Semenova, D S Schmidt, T H Taylor Jr, H Li, E Steward-Clark, S D Soroka, M M Ballard, C P Quinn
(Affiliation: Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. vsemenova at cdc.gov)
|
| Journal | Vaccine
(Vaccine)
Vol. 25
Issue 10
Pg. 1780-8
(Feb 26 2007)
ISSN: 0264-410X [Print] Netherlands |
| PMID | 17229495
(Publication Type: Comparative Study, Journal Article)
|
| Chemical References |
- Anthrax Vaccines
- Antibodies, Bacterial
- Antigens, Bacterial
- Antitoxins
- Bacterial Toxins
- Immunoglobulin G
- anthrax toxin
|
| Topics |
- Adult
- Aged
- Anthrax
(immunology)
- Anthrax Vaccines
(immunology)
- Antibodies, Bacterial
(blood, classification)
- Antigens, Bacterial
(immunology)
- Antitoxins
(blood)
- Bacterial Toxins
(immunology)
- Female
- Humans
- Immunoglobulin G
(blood, classification)
- Male
- Middle Aged
|